The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Interleukin 17A-Global Market Insights and Sales Trends 2025
Synopsis
The global Interleukin 17A market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Interleukin 17A in various end use industries. The expanding demands from the Chronic Pain, Liver Cancer, Kidney Cancer and Others, are propelling Interleukin 17A market. ABY-035, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the CNTO-6785 segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Interleukin 17A market, driven by demand from China, the second largest economy with some signs of stabilising, the Interleukin 17A market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Interleukin 17A, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Interleukin 17A market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Interleukin 17A market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Interleukin 17A sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Interleukin 17A covered in this report include AbbVie Inc, Abeome Corporation, Affibody AB, Cell Medica Limited, Eli Lilly and Company, Johnson & Johnson, Merck KGaA, Novartis AG and Orega Biotech SAS, etc.
The global Interleukin 17A market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AbbVie Inc
Abeome Corporation
Affibody AB
Cell Medica Limited
Eli Lilly and Company
Johnson & Johnson
Merck KGaA
Novartis AG
Orega Biotech SAS
Global Interleukin 17A market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Interleukin 17A market, Segment by Type:
ABY-035
CNTO-6785
DLX-2882
Others
Global Interleukin 17A market, by Application
Chronic Pain
Liver Cancer
Kidney Cancer
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Interleukin 17A manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Interleukin 17A in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Interleukin 17A market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Interleukin 17A in various end use industries. The expanding demands from the Chronic Pain, Liver Cancer, Kidney Cancer and Others, are propelling Interleukin 17A market. ABY-035, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the CNTO-6785 segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Interleukin 17A market, driven by demand from China, the second largest economy with some signs of stabilising, the Interleukin 17A market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Interleukin 17A, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Interleukin 17A market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Interleukin 17A market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Interleukin 17A sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Interleukin 17A covered in this report include AbbVie Inc, Abeome Corporation, Affibody AB, Cell Medica Limited, Eli Lilly and Company, Johnson & Johnson, Merck KGaA, Novartis AG and Orega Biotech SAS, etc.
The global Interleukin 17A market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AbbVie Inc
Abeome Corporation
Affibody AB
Cell Medica Limited
Eli Lilly and Company
Johnson & Johnson
Merck KGaA
Novartis AG
Orega Biotech SAS
Global Interleukin 17A market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Interleukin 17A market, Segment by Type:
ABY-035
CNTO-6785
DLX-2882
Others
Global Interleukin 17A market, by Application
Chronic Pain
Liver Cancer
Kidney Cancer
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Interleukin 17A manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Interleukin 17A in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Interleukin 17A Market Overview
1.1 Interleukin 17A Product Overview
1.2 Interleukin 17A Market Segment by Type
1.2.1 ABY-035
1.2.2 CNTO-6785
1.2.3 DLX-2882
1.2.4 Others
1.3 Global Interleukin 17A Market Size by Type
1.3.1 Global Interleukin 17A Market Size Overview by Type (2018-2029)
1.3.2 Global Interleukin 17A Historic Market Size Review by Type (2018-2023)
1.3.3 Global Interleukin 17A Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Interleukin 17A Sales Breakdown by Type (2018-2023)
1.4.2 Europe Interleukin 17A Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Interleukin 17A Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Interleukin 17A Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Interleukin 17A Sales Breakdown by Type (2018-2023)
2 Global Interleukin 17A Market Competition by Company
2.1 Global Top Players by Interleukin 17A Sales (2018-2023)
2.2 Global Top Players by Interleukin 17A Revenue (2018-2023)
2.3 Global Top Players by Interleukin 17A Price (2018-2023)
2.4 Global Top Manufacturers Interleukin 17A Manufacturing Base Distribution, Sales Area, Product Type
2.5 Interleukin 17A Market Competitive Situation and Trends
2.5.1 Interleukin 17A Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Interleukin 17A Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Interleukin 17A as of 2022)
2.7 Date of Key Manufacturers Enter into Interleukin 17A Market
2.8 Key Manufacturers Interleukin 17A Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Interleukin 17A Status and Outlook by Region
3.1 Global Interleukin 17A Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Interleukin 17A Historic Market Size by Region
3.2.1 Global Interleukin 17A Sales in Volume by Region (2018-2023)
3.2.2 Global Interleukin 17A Sales in Value by Region (2018-2023)
3.2.3 Global Interleukin 17A Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Interleukin 17A Forecasted Market Size by Region
3.3.1 Global Interleukin 17A Sales in Volume by Region (2024-2029)
3.3.2 Global Interleukin 17A Sales in Value by Region (2024-2029)
3.3.3 Global Interleukin 17A Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Interleukin 17A by Application
4.1 Interleukin 17A Market Segment by Application
4.1.1 Chronic Pain
4.1.2 Liver Cancer
4.1.3 Kidney Cancer
4.1.4 Others
4.2 Global Interleukin 17A Market Size by Application
4.2.1 Global Interleukin 17A Market Size Overview by Application (2018-2029)
4.2.2 Global Interleukin 17A Historic Market Size Review by Application (2018-2023)
4.2.3 Global Interleukin 17A Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Interleukin 17A Sales Breakdown by Application (2018-2023)
4.3.2 Europe Interleukin 17A Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Interleukin 17A Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Interleukin 17A Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Interleukin 17A Sales Breakdown by Application (2018-2023)
5 North America Interleukin 17A by Country
5.1 North America Interleukin 17A Historic Market Size by Country
5.1.1 North America Interleukin 17A Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Interleukin 17A Sales in Volume by Country (2018-2023)
5.1.3 North America Interleukin 17A Sales in Value by Country (2018-2023)
5.2 North America Interleukin 17A Forecasted Market Size by Country
5.2.1 North America Interleukin 17A Sales in Volume by Country (2024-2029)
5.2.2 North America Interleukin 17A Sales in Value by Country (2024-2029)
6 Europe Interleukin 17A by Country
6.1 Europe Interleukin 17A Historic Market Size by Country
6.1.1 Europe Interleukin 17A Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Interleukin 17A Sales in Volume by Country (2018-2023)
6.1.3 Europe Interleukin 17A Sales in Value by Country (2018-2023)
6.2 Europe Interleukin 17A Forecasted Market Size by Country
6.2.1 Europe Interleukin 17A Sales in Volume by Country (2024-2029)
6.2.2 Europe Interleukin 17A Sales in Value by Country (2024-2029)
7 Asia-Pacific Interleukin 17A by Region
7.1 Asia-Pacific Interleukin 17A Historic Market Size by Region
7.1.1 Asia-Pacific Interleukin 17A Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Interleukin 17A Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Interleukin 17A Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Interleukin 17A Forecasted Market Size by Region
7.2.1 Asia-Pacific Interleukin 17A Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Interleukin 17A Sales in Value by Region (2024-2029)
8 Latin America Interleukin 17A by Country
8.1 Latin America Interleukin 17A Historic Market Size by Country
8.1.1 Latin America Interleukin 17A Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Interleukin 17A Sales in Volume by Country (2018-2023)
8.1.3 Latin America Interleukin 17A Sales in Value by Country (2018-2023)
8.2 Latin America Interleukin 17A Forecasted Market Size by Country
8.2.1 Latin America Interleukin 17A Sales in Volume by Country (2024-2029)
8.2.2 Latin America Interleukin 17A Sales in Value by Country (2024-2029)
9 Middle East and Africa Interleukin 17A by Country
9.1 Middle East and Africa Interleukin 17A Historic Market Size by Country
9.1.1 Middle East and Africa Interleukin 17A Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Interleukin 17A Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Interleukin 17A Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Interleukin 17A Forecasted Market Size by Country
9.2.1 Middle East and Africa Interleukin 17A Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Interleukin 17A Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 AbbVie Inc
10.1.1 AbbVie Inc Company Information
10.1.2 AbbVie Inc Introduction and Business Overview
10.1.3 AbbVie Inc Interleukin 17A Sales, Revenue and Gross Margin (2018-2023)
10.1.4 AbbVie Inc Interleukin 17A Products Offered
10.1.5 AbbVie Inc Recent Development
10.2 Abeome Corporation
10.2.1 Abeome Corporation Company Information
10.2.2 Abeome Corporation Introduction and Business Overview
10.2.3 Abeome Corporation Interleukin 17A Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Abeome Corporation Interleukin 17A Products Offered
10.2.5 Abeome Corporation Recent Development
10.3 Affibody AB
10.3.1 Affibody AB Company Information
10.3.2 Affibody AB Introduction and Business Overview
10.3.3 Affibody AB Interleukin 17A Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Affibody AB Interleukin 17A Products Offered
10.3.5 Affibody AB Recent Development
10.4 Cell Medica Limited
10.4.1 Cell Medica Limited Company Information
10.4.2 Cell Medica Limited Introduction and Business Overview
10.4.3 Cell Medica Limited Interleukin 17A Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Cell Medica Limited Interleukin 17A Products Offered
10.4.5 Cell Medica Limited Recent Development
10.5 Eli Lilly and Company
10.5.1 Eli Lilly and Company Company Information
10.5.2 Eli Lilly and Company Introduction and Business Overview
10.5.3 Eli Lilly and Company Interleukin 17A Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Eli Lilly and Company Interleukin 17A Products Offered
10.5.5 Eli Lilly and Company Recent Development
10.6 Johnson & Johnson
10.6.1 Johnson & Johnson Company Information
10.6.2 Johnson & Johnson Introduction and Business Overview
10.6.3 Johnson & Johnson Interleukin 17A Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Johnson & Johnson Interleukin 17A Products Offered
10.6.5 Johnson & Johnson Recent Development
10.7 Merck KGaA
10.7.1 Merck KGaA Company Information
10.7.2 Merck KGaA Introduction and Business Overview
10.7.3 Merck KGaA Interleukin 17A Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Merck KGaA Interleukin 17A Products Offered
10.7.5 Merck KGaA Recent Development
10.8 Novartis AG
10.8.1 Novartis AG Company Information
10.8.2 Novartis AG Introduction and Business Overview
10.8.3 Novartis AG Interleukin 17A Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Novartis AG Interleukin 17A Products Offered
10.8.5 Novartis AG Recent Development
10.9 Orega Biotech SAS
10.9.1 Orega Biotech SAS Company Information
10.9.2 Orega Biotech SAS Introduction and Business Overview
10.9.3 Orega Biotech SAS Interleukin 17A Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Orega Biotech SAS Interleukin 17A Products Offered
10.9.5 Orega Biotech SAS Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Interleukin 17A Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Interleukin 17A Industrial Chain Analysis
11.4 Interleukin 17A Market Dynamics
11.4.1 Interleukin 17A Industry Trends
11.4.2 Interleukin 17A Market Drivers
11.4.3 Interleukin 17A Market Challenges
11.4.4 Interleukin 17A Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Interleukin 17A Distributors
12.3 Interleukin 17A Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
